Prospective, Multicenter, Open Label and Single-arm Study of Darbepoetin Alfa for Anemia in Myelodisplastic Syndrome Patients.
Clinical trial NCT01039350 · TERMINATED
Trial details
- NCT number
- NCT01039350
- Sponsor
- Fundacion para el Estudio de la Hematologia y Hemoterapia en Aragon
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2008-07-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.